INTERNATIONAL PATENT: ORIC PHARMACEUTICALS, INC. FILES APPLICATION FOR "TREATMENT OF CANCER USING COMBINATIONS OF AN EED INHIBITOR AND AN AKT INHIBITOR"

GENEVA, April 14 -- ORIC PHARMACEUTICALS, INC. (240 E. Grand Avenue, 2nd FloorSouth San Francisco, California 94080) filed a patent application (PCT/US2025/048933) for "TREATMENT OF CANCER USING COMBINATIONS OF AN EED INHIBITOR AND AN AKT INHIBITOR" on Oct 01, 2025. With publication no. WO/2026/076064, the details related to the patent application was published on Apr 09, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JUNTTILA, Melissa R. (240 E. Grand Avenue, 2nd FloorSouth San Francisco, California 94080), EDGAR, Kyle Andrew (240 E. Grand Avenue, 2nd FloorSouth San Francisco, California 9...